NCT06864897

Brief Summary

This 10-year follow-up study aims to further investigate long-term migration patterns of the uncemented Delta-TT cup and H-MAX S stem, comparing outcomes between ceramic and polyethylene liners. Given the predictive value of early RSA migration patterns at the 2-year mark for identifying implants at risk of aseptic loosening, we hypothesize that the Delta-TT cup will demonstrate good stability at the 10-year postoperative mark. Besides, it is hypothesized that migration of Delta TT-cups is comparable between ceramic and polyethylene liners. The primary objective of this study is to measure the long-term stability of the Delta TT cup, combined with either a ceramic or cross-linked polyethylene liner, by means of RSA at 10-years postoperatively. Secondary objectives are to measure long-term stability of the H-MAX S stem, by means of RSA at 10-year postoperatively. Furthermore the study aims to measure implant survival rates and patient-reported outcomes for both the Delta-TT cup and H-MAX S stem, comparing outcomes between the ceramic and polyethylene group.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
36mo left

Started Oct 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Oct 2024May 2029

Study Start

First participant enrolled

October 10, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 7, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2029

Expected
Last Updated

March 14, 2025

Status Verified

December 1, 2024

Enrollment Period

1.6 years

First QC Date

February 25, 2025

Last Update Submit

March 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Long-term (10-year) migration pattern of the Delta-TT cup compared between a ceramic and polyethylene liner.

    Measured in 3D translations and rotations by means of Radiostereometric X-ray images at 10-years postoperatively. Data will be summarized by treatment group. A mixed model analysis will be performed to assess cup migration, with liner type (polyethylene vs. ceramic) as the primary independent value. The primary outcome is the effect of the liner type on implant migration. Differences are considered significant for p-values below 0.05.

    10 Years

Secondary Outcomes (4)

  • Long-term (10-year) migration pattern of the H-MAX S Stem compared between a ceramic and polyethylene liner.

    10 years

  • Implant survival of the Delta TT cup and H-MAX S stem.

    10 years

  • Radiographic signs of osteolysis around the Delta-TT cup.

    10 years

  • Radiographic signs of osteolysis around the H-Max S stem.

    10 years

Study Arms (2)

Polyethylene liner

Device: Total hip prosthesis

Ceramic liner

Device: Total hip prothesis

Interventions

Total hip prothesis with a Delta-TT cup, H MAX S Stem and a ceramic liner

Ceramic liner

Total hip prosthesis with a Delta TT cup, H MAX S stem and polyethylene liner

Polyethylene liner

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients enrolled in the initial Delta-TT trial are eligible for inclusion. These patients recieved a hip prothesis including a Delta-TT cup, a H-MAX S Stem and either a polyethylene or a ceramic Liner.

You may qualify if:

  • Enrolled in the initial Delta-TT trial

You may not qualify if:

  • Patient is unable or unwilling to sign the Informed Consent specific to this study.
  • Patient is unsuitable for participation in the study based on the investigator's judgement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OLVG Hospital

Amsterdam, North Holland, 1091 AC, Netherlands

RECRUITING

MeSH Terms

Conditions

Hip Dislocation

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesHip Injuries

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Rudolf Poolman, PhD

    Orthopedic Surgeon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amdanda Klaassen, Msc

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 7, 2025

Study Start

October 10, 2024

Primary Completion

May 1, 2026

Study Completion (Estimated)

May 1, 2029

Last Updated

March 14, 2025

Record last verified: 2024-12

Locations